From Wood Pulp to a Candidate Medicine: Green Manufacturing Technologies Enable Production of Nemtabrutinib
VirtualBen Turnbull and Mike Di Maso, Associate Principal Scientists at Merck Sponsored by ACS Webinars and ACS Green Chemistry Pharmaceutical Roundtable September 8th, 11-Noon, Online via Zoom, Free, Registration required Green manufacturing technologies including biocatalysis, enzyme immobilization, and continuous manufacturing in a packed-bed reactor enabled Merck to produce investigational leukemia drug nemtabrutinib from a biorenewable […]